Article I of the Paris Charter Against Cancer dictates that cancer patient rights are human rights, and that the currently evolving movement to define and adopt cancer patients’ rights is critical to recognizing and protecting the value and dignity of individuals with cancer throughout the world.
How have cancer patient rights changed since the signing of the Charter?
On a general global level, there has been progress in the following:
- World Health Organization (WHO) Initiatives: The WHO has launched several global initiatives to improve cancer care. This included the Global Action Plan for the Prevention and Control of Noncommunicable Diseases, and the creation of the International Agency for Research on Cancer (IARC).
- IARC Initiatives: The IARC is a specialized international cancer agency attached to the WHO, focused on international collaboration in cancer research, with a particular focus on exploring how environmental and lifestyle factors affect cancer risks. The organization has played a vital role in illustrating how heavy the burden of cancer is. In 2016, the IARC launched the Global Cancer Observatory (GCO). The GCO is designed to provide global statistics on cancer research and control.
- International Collaborations: Cross-border collaborations and partnerships have increased through institutions like the IARC have increased, leading to a better exchange of information on research, clinical trials, and treatment protocols.
- Focus on expanding programs designed to help cancer patients & survivors: Multiple organizations around the world have created things like patient advocacy programs, navigation programs, care plan programs and expanded access programs. These programs are designed to assist cancer patients and survivors in helping them to access treatments for their cancer, to navigate the healthcare system, gain financial stability, employment opportunities and to offer psychosocial support while they are undergoing or after the have undergone treatment.
- Telemedicine and Digital Health: The adoption of telemedicine and digital health solutions has improved access to care for cancer patients, especially in rural or underserved areas. These technologies have become increasingly important, particularly in response to the COVID-19 pandemic.
Several countries and unions have implemented additional social efforts, regulations, and laws that now protect cancer patients as well:
United States of America:
The Patient Protection and Affordable Care Act (ACA)(2010): Insurers cannot deny coverage to individuals with pre-existing conditions, such as cancer, insurance plans must cover essential health benefits, including cancer treatment and lifetime limits on insurance coverage must be removed, ensuring that cancer patients can receive the necessary treatment without fear of running out of coverage – decreasing the financial burden associated with cancer treatments.
The Genetic Information Nondiscrimination Act (GINA) (2008): The act protects individuals from being discriminated against based on their genetic information in health insurance and employment. This is crucial for cancer patients who may undergo genetic testing to assess cancer risk.
The Right to Try Act (2018): Allows patients with life-threatening conditions, such as cancer, to access experimental treatments that have passed Phase I of clinical trials but are not yet fully approved by the FDA. This provides an avenue for patients to try potentially life-saving treatments when no other options are available.
The Americans with Disabilities Act (ADA): Amendments to and enforcement of the ADA have strengthened protections for cancer patients in the workplace. Employers are required to provide reasonable accommodations and cannot discriminate based on an individual’s cancer diagnosis.
European Union (EU):
Patients’ Rights in Cross-Border Healthcare Directive (2011/24/EU): Ensures that EU citizens can access healthcare services, including cancer treatments, in other member states and be reimbursed by their home country. It aims to improve access to high-quality cancer care and promote patient mobility within Europe.
General Data Protection Regulation (GDPR) (2018): Enhances the protection of personal data, including health data, ensuring that cancer patients’ privacy is safeguarded.
National Health Strategies: Many European countries have developed national cancer control plans and strategies aimed at improving cancer care and patient outcomes. These plans typically include provisions for early detection, access to treatment, research, and support services.
Regulation on Clinical Trials (EU No 536/2014): This regulation aims to harmonize and streamline the approval process for clinical trials across EU member states, making it easier for cancer patients to participate in clinical trials and access new treatments.
Protection Against Discrimination
European Pillar of Social Rights (2017): An initiative that includes principles supporting equal opportunities and access to the labor market, fair working conditions, and social protection and inclusion. These principles help protect cancer patients from discrimination in the workplace and ensure they receive adequate social support.
National Anti-Discrimination Laws: Many European countries have strengthened their anti-discrimination laws to protect cancer patients. These laws often cover employment, insurance, and access to healthcare services.
European Cancer Patient Coalition (ECPC): The ECPC represents cancer patients across Europe and advocates for better cancer care policies, access to treatment, and patient rights. The coalition works to ensure that the voices of cancer patients are heard in policy-making processes.
Patient Navigation and Support Services: There has been a growth in patient navigation programs and support services across Europe. These programs help cancer patients navigate the healthcare system, access necessary treatments, and receive psychosocial support.
Palliative Care and Pain Management: European countries have made significant strides in integrating palliative care into their healthcare systems. Policies and guidelines have been developed to ensure that cancer patients have access to comprehensive pain management and palliative care services.
Europe’s Beating Cancer Plan (2021): This comprehensive plan aims to address cancer through prevention, early detection, diagnosis and treatment, and quality of life for cancer patients and survivors. It includes initiatives to reduce cancer inequalities and improve cancer care across the EU.
European Reference Networks (ERNs): ERNs for rare cancers facilitate cross-border collaboration and knowledge sharing among healthcare providers, ensuring that cancer patients with rare conditions can access specialized care and expertise.
Asia:
National Cancer Control Programs: Many Asian countries have implemented national cancer control programs (NCCPs) aimed at reducing cancer incidence and mortality through prevention, early detection, treatment, and palliative care. Examples include: India’s National Cancer Control Program, which has been revised to include prevention, early detection, treatment, and palliative care components, and China’s Cancer Prevention and Control Plan (2015-2020), which focused on comprehensive strategies including cancer screening, treatment, and research.
Health Insurance Reforms: Several countries have reformed their health insurance systems to improve access to cancer treatment. Japan’s Cancer Control Act (2007) mandated comprehensive cancer control measures, including early detection and equal access to treatment and South Korea’s National Health Insurance expanded coverage for cancer treatment, reducing the financial burden on patients.
Palliative Care and Pain Management: Palliative care services have been expanded in several Asian countries to ensure that cancer patients have access to pain management and supportive care. India launched it’s National Programme for Palliative Care (NPPC) in 2012 to improve access to palliative care services across the country, and Singapore’s Palliative Care Services were enhanced through policies and training programs designed to integrate palliative care into mainstream healthcare.
Regulatory Reforms: Some countries have streamlined their regulatory frameworks to facilitate faster approval and access to new cancer treatments and clinical trials:
- China’s Drug Approval Reforms: The National Medical Products Administration has implemented reforms to speed up the approval process for new cancer drugs.
- Japan’s SAKIGAKE Designation: This system accelerates the development and review of innovative medical products, including cancer treatments.
Collaboration with International Organizations: Many Asian countries have collaborated with international organizations to improve cancer care:
- WHO and IARC Initiatives: Countries like Thailand and Malaysia have worked with the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC) to enhance cancer registries and control programs.
Anti-Discrimination Laws: Some Asian countries have enacted laws to protect cancer patients from discrimination in employment and insurance. Japan’s Basic Act for Anti-Cancer Measures includes provisions to protect cancer patients from discrimination, and India’s Rights of Persons with Disabilities Act (2016) provides legal protection against discrimination for individuals with disabilities, including those with cancer.
Non-Governmental Organizations (NGOs): Numerous NGOs across Asia advocate for cancer patient rights, provide support services, and raise awareness:
- The National Cancer Society of Malaysia (NCSM): Offers support services, education, and advocacy for cancer patients.
- Indian Cancer Society: Provides financial aid, counseling, and support for cancer patients and their families.
Patient Navigation Programs: These programs help cancer patients navigate the complex healthcare system, ensuring they receive timely and appropriate care:
- Philippines Cancer Society: Offers patient navigation services to assist with treatment planning and support.
Precision Medicine and Genetic Testing: Advances in precision medicine and genetic testing have led to more personalized cancer treatments in several Asian countries:
- Japan and South Korea have been successful in implementing precision medicine initiatives and cancer genomics programs.
Telemedicine: The adoption of telemedicine has improved access to cancer care, particularly in rural and remote areas. For example, China’s Telemedicine Programs have significantly expanded in recent years, providing remote consultations and follow-up care for cancer patients.
ASEAN Cancer Registry: Enhances collaboration among Southeast Asian countries to improve cancer data collection, management and treatment methods.